Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense
2016 Standout
Obesity Stigma: Important Considerations for Public Health
2010 Standout
A Systematic Review of Factors Associated with Health-Related Quality of Life in Adolescents and Adults with Cystic Fibrosis
2015
Parental influence and obesity prevention in pre‐schoolers: a systematic review of interventions
2010
Interventions for the eradication of methicillin-resistantStaphylococcus aureus(MRSA) in people with cystic fibrosis
2013
A Comparison of Bayesian Methods for Haplotype Reconstruction from Population Genotype Data
2003 Standout
Quality of life and healthcare utilisation in cystic fibrosis: a multicentre study
2012
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR
2015 Standout
Development and evaluation of a palliative care curriculum for cystic fibrosis healthcare providers
2015
Identifying barriers to treatment adherence and related attitudinal patterns in adolescents with cystic fibrosis
2010
Cystic fibrosis
2016 Standout
Nucleotide signalling during inflammation
2014 StandoutNature
Azithromycin in Patients With Cystic Fibrosis Chronically Infected With Pseudomonas aeruginosa
2003
Study protocol: evaluation of ‘JenMe’, a commercially-delivered weight management program for adolescents: a randomised controlled trial
2015
Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST)
2014
A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial
2014
Schizophrenia
2009 Standout
Pancreatic enzyme replacement therapy for people with cystic fibrosis
2014
Managing Cystic Fibrosis
2011
Clinical trials in cystic fibrosis
2007
Perceptions of barriers and facilitators: Self-management decisions by older adolescents and adults with CF
2010
Identification and Evaluation of Children With Autism Spectrum Disorders
2007
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
The Effectiveness of Mobile-Health Technology-Based Health Behaviour Change or Disease Management Interventions for Health Care Consumers: A Systematic Review
2013 Standout
Longitudinal Trends in Health-Related Quality of Life in Adults With Cystic Fibrosis
2013
Longitudinal association between medication adherence and lung health in people with cystic fibrosis
2011
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
Predicting the Functional Effect of Amino Acid Substitutions and Indels
2012 Standout
Body satisfaction, nutritional adherence, and quality of life in youth with cystic fibrosis
2011
Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association
2022 Standout
Evolving Healthcare Delivery in Neurology During the Coronavirus Disease 2019 (COVID-19) Pandemic
2020
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
2011 Standout
Adherence to nebulised therapies in adolescents with cystic fibrosis is best on week-days during school term-time
2013
Clinical Management of Psychosocial Concerns Related to Food Allergy
2016
Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation
2014
Rationale and design of “Hearts & Parks”: study protocol for a pragmatic randomized clinical trial of an integrated clinic-community intervention to treat pediatric obesity
2020
Accurate Assessment of Adherence
2011
Family-Based Approaches to Cardiovascular Health Promotion
2016
Cystic Fibrosis Foundation and European Cystic Fibrosis Society Survey of cystic fibrosis mental health care delivery
2015
Phase 2 Randomized Safety and Efficacy Trial of Nebulized Denufosol Tetrasodium in Cystic Fibrosis
2007
Open adherence monitoring using routine data download from an adaptive aerosol delivery nebuliser in children with cystic fibrosis
2009
International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety
2015
Cystic fibrosis genetics: from molecular understanding to clinical application
2014 Standout
Efficacy and Safety of Inhaled Aztreonam Lysine for Airway Pseudomonas in Cystic Fibrosis
2009
Barriers to adherence in adolescents and young adults with cystic fibrosis: a questionnaire study in young patients and their parents
2011
Long-term treatment with oral N-acetylcysteine: Affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial
2014
Preventing Weight Gain and Obesity: Indirect Effects of the Family Check-Up in Early Childhood
2014
An Introduction to Latent Variable Mixture Modeling (Part 1): Overview and Cross-Sectional Latent Class and Latent Profile Analyses
2013 Standout
Long-term multicentre randomised controlled study of high frequency chest wall oscillation versus positive expiratory pressure mask in cystic fibrosis
2013
‘Small Changes' to Diet and Physical Activity Behaviors for Weight Management
2013 Standout
Autism
2013 Standout
Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial
2015
Atherosclerosis
2019 Standout
Airway Mucus Function and Dysfunction
2010 Standout
Stigma, obesity, and the health of the nation's children.
2007
Impact of Informing Overweight Individuals about the Role of Genetics in Obesity: An Online Experimental Study
2013 Standout
Symptoms of Sleep Apnea and Polysomnography as Predictors of Poor Quality of Life in Overweight Children and Adolescents
2007
Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic Fibrosis
2008
Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers: results of The International Depression Epidemiological Study across nine countries
2014
Update on Key Emerging Challenges in Cystic Fibrosis
2014 Standout
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management
2017 Standout
Validation of the Pediatric Cardiac Quality of Life Inventory
2010
22q11.2 deletion syndrome
2015 Standout
Health-related quality of life in obese children and adolescents
2009
Ivacaftor in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation
2012
Adherence with tobramycin inhaled solution and health care utilization
2011
Experience sampling research in psychopathology: opening the black box of daily life
2009
Treatment of lung infection in patients with cystic fibrosis: Current and future strategies
2012
Clinical Mechanism of the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor in G551D-mediated Cystic Fibrosis
2014
Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with a G551D Mutation
2013
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Lumacaftor/Ivacaftor in Patients Aged 6–11 Years with Cystic Fibrosis and Homozygous for F508del-CFTR
2017
Improvement in Quality of Life after Therapy for Mycobacterium abscessus Group Lung Infection. A Prospective Cohort Study
2015
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Review article: the nutritional and pharmacological consequences of obesity surgery
2014
Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis
2015
How Effective Are Short Message Service Reminders at Increasing Clinic Attendance? A Meta‐Analysis and Systematic Review
2011
Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis
2017
Emergent Life Cycle: The Tension Between Knowledge Change and Knowledge Retention in Open Online Coproduction Communities
2014
Diagnosis and Management of Childhood Obstructive Sleep Apnea Syndrome
2012 Standout
Longevity of Patients With Cystic Fibrosis in 2000 to 2010 and Beyond: Survival Analysis of the Cystic Fibrosis Foundation Patient Registry
2014
Interventions for preventing obesity in children
2019 Standout
Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis
2015
Interventions for enhancing medication adherence
2014 Standout
Biofilm-Related Infections: Bridging the Gap between Clinical Management and Fundamental Aspects of Recalcitrance toward Antibiotics
2014 Standout
Mobile phone messaging reminders for attendance at healthcare appointments
2013 Standout
Digital Entrepreneurship: Toward a Digital Technology Perspective of Entrepreneurship
2016 Standout
Journal of Inter Personal Violence
2004 Standout
Iron-Deficiency Anemia
2015 Standout
Digital Innovation Management: Reinventing Innovation Management Research in a Digital World
2017 Standout
Randomized, Controlled Trial of an Intervention for Toddlers With Autism: The Early Start Denver Model
2009 Standout
Quality of Life among Children with Velocardiofacial Syndrome
2010
Network Analysis: An Integrative Approach to the Structure of Psychopathology
2013 Standout
Adherence to Pancreatic Enzyme Supplementation: In Adolescents with Cystic Fibrosis
2012
Stigma as a Fundamental Cause of Population Health Inequalities
2013 Standout
Trends in Obesity Prevalence Among Children and Adolescents in the United States, 1988-1994 Through 2013-2014
2016 Standout
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
Anti-PcrV antibody in cystic fibrosis: A novel approach targeting Pseudomonas aeruginosa airway infection
2013
Medication Adherence Measures: An Overview
2015 Standout
Lung Infections Associated with Cystic Fibrosis
2002 Standout
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation and Management
2012 Standout
American Heart Association Childhood Obesity Research Summit Report
2009
Fair Allocation of Scarce Medical Resources in the Time of Covid-19
2020 Standout
Diagnosis and Management of Childhood Obstructive Sleep Apnea Syndrome
2012 Standout
An Integrated Clinic-Community Partnership for Child Obesity Treatment: A Randomized Pilot Trial
2017
Works of Avani C. Modi being referenced
Development and Initial Validation of an Obesity‐specific Quality‐of‐life Measure for Children: Sizing Me Up
2009
Predictors of Health‐Related Quality of Life in Obese Youth
2006
Determination of the Minimal Clinically Important Difference Scores for the Cystic Fibrosis Questionnaire-Revised Respiratory Symptom Scale in Two Populations of Patients With Cystic Fibrosis and Chronic Pseudomonas aeruginosa Airway Infection
2009
Weight‐specific Health‐related Quality of Life in Adolescents With Extreme Obesity
2008
Depressive symptoms in children with cystic fibrosis and parents and its effects on adherence to airway clearance
2010
Perceived Barriers to Clinic Appointments for Adolescents With Sickle Cell Disease
2009
Lessons learned from a randomized trial of airway secretion clearance techniques in cystic fibrosis
2010
Validation of a Disease-Specific Measure of Health-Related Quality of Life for Children with Cystic Fibrosis
2003
Evidence-based Assessment of Adherence to Medical Treatments in Pediatric Psychology
2007
Patterns of Nonadherence to Antiepileptic Drug Therapy in Children With Newly Diagnosed Epilepsy
2011
Relations between depressive and anxious symptoms and quality of life in caregivers of children with cystic fibrosis
2009
Barriers to Treatment Adherence for Children with Cystic Fibrosis and Asthma: What Gets in the Way?
2006
A Survey of Autism Knowledge in a Health Care Setting
2005
Controlled Study of Critical Parent and Family Factors in the Obesigenic Environment
2007
Trajectories of Adherence to Airway Clearance Therapy for Patients with Cystic Fibrosis
2010
Adherence to vitamin supplementation following adolescent bariatric surgery
2013
White Coat Adherence over the First Year of Therapy in Pediatric Epilepsy
2012
A multi-method assessment of treatment adherence for children with cystic fibrosis
2006
Development and Validation of the Cystic Fibrosis Questionnaire in the United States
2005
Systematic review of health-related quality of life measures for children with respiratory conditions
2008
Assessing Weight‐Related Quality of Life in Adolescents
2006
Development and Preliminary Implementation of a Psychosocial Service Into Standard Medical Care for Pediatric Epilepsy
2013
The Influence of Parental Supervision on Medical Adherence in Adolescents With Cystic Fibrosis: Developmental Shifts From Pre to Late Adolescence
2008
Keeping people with epilepsy safe during the COVID-19 pandemic
2020
Health-Related Quality of Life and Depressive Symptoms in Adolescents With Extreme Obesity Presenting for Bariatric Surgery
2006